Valuation: CVRx, Inc.

Market Cap 35.97M 32.06M 29.7M 27M 50.67M 3.41B 51.5M 356M 140M 1.78B 135M 132M 5.7B P/E 2026 *
-0.67x
P/E 2027 * -0.71x
Enterprise Value 46.47M 41.42M 38.37M 34.89M 65.47M 4.41B 66.54M 460M 181M 2.3B 174M 171M 7.36B EV / Sales 2026 *
0.79x
EV / Sales 2027 * 1.19x
Free-Float
85.05%
Yield 2026 *
-
Yield 2027 * -
1 day+3.85%
1 week-8.78%
Current month-22.86%
1 month-55.59%
3 months-72.51%
6 months-81.66%
Current year-80.99%
1 week 1.26
Extreme 1.255
1.44
1 month 1.26
Extreme 1.255
3.07
Current year 1.26
Extreme 1.255
9.84
1 year 1.26
Extreme 1.255
11.3
3 years 1.26
Extreme 1.255
33.14
5 years 1.26
Extreme 1.255
33.14
10 years 1.26
Extreme 1.255
33.14
Manager TitleAgeSince
Chief Executive Officer 60 2024-02-11
Director of Finance/CFO 54 2026-10-11
Director of Finance/CFO 43 2020-09-30
Director TitleAgeSince
Director/Board Member 61 2008-09-30
Director/Board Member 57 2020-06-30
Director/Board Member 52 2020-06-30
Date Insider Type Main position Quantity % Market Cap. Importance
8/13/26 Buy

Chief Operating Officer

26,223 0.0988%
8/12/26 Sell

Chief Operating Officer

-1,309 0.0049%
6/1/26
Treo Ventures LLC
OtherCompany 0 0% -
Change 5-day change 1-year change 3-year change Capi.($)
+3.85%-8.78%-86.43%-89.49% 34.63M
-0.79%+2.20%-19.04%+9.03% 181B
-2.09%+0.91%-3.14%+28.22% 116B
+1.11%+5.43%-20.43%+11.00% 113B
-1.52%+3.61%-51.34%-6.22% 79.83B
-0.27%+4.60%+4.72%+79.05% 65.06B
+0.76%+1.82%+14.12%+76.36% 54.35B
-0.53%+0.98%+0.87%-25.92% 52.23B
-0.81%+6.08%-12.53%+30.57% 44.15B
-0.07%+0.07%+29.10%-0.07% 32.47B
Average -0.04%+1.81%-14.41%+11.25% 73.86B
Weighted average by Cap. -0.57%+2.98%-11.81%+20.23%

Financials

2026 *2027 *
Net sales 58.85M 52.46M 48.6M 44.19M 82.91M 5.58B 84.28M 583M 229M 2.92B 221M 216M 9.32B 66.18M 58.99M 54.65M 49.69M 93.24M 6.27B 94.77M 655M 258M 3.28B 248M 243M 10.48B
Net income -53.45M -47.65M -44.14M -40.13M -75.3M -5.07B -76.54M -529M -208M -2.65B -201M -196M -8.47B -52.14M -46.47M -43.05M -39.14M -73.45M -4.94B -74.66M -516M -203M -2.58B -196M -192M -8.26B
Net Debt 10.5M 9.36M 8.67M 7.89M 14.8M 996M 15.04M 104M 40.91M 520M 39.41M 38.58M 1.66B 42.94M 38.28M 35.46M 32.24M 60.49M 4.07B 61.49M 425M 167M 2.13B 161M 158M 6.8B
Projected Income Statement - Annual - CVRx, Inc.
Logo CVRx, Inc.
CVRx, Inc. is a commercial-stage medical device company. The Company is focused on developing, manufacturing and commercializing advanced neuromodulation solutions for patients with cardiovascular diseases. The Company's integrated platform technology, Barostim, is designed to leverage the power of the brain and nervous system to address the imbalance of the autonomic nervous system (ANS), which causes heart failure with reduced ejection fraction (HFrEF) and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy (BAT) by sending imperceptible and persistent electrical pulses to baroreceptors located in the wall of the carotid artery to signal the brain to modulate cardiovascular function. Barostim is a minimally invasive neuromodulation device that consists of two implantable components, an implantable pulse generator (IPG) and a stimulation lead, and is programmed by a wireless clinician-controlled programmer that communicates with the IPG.
Employees
223
Date Price Change Volume
26-10-19 US$1.350 +3.85% 357,994
26-10-16 US$1.300 -6.47% 382,715
26-10-15 US$1.390 +3.73% 361,671
26-10-14 US$1.340 -1.47% 893,428
26-10-13 US$1.360 -8.11% 490,504
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - CVRx, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
1.350USD
Average target price
4.583USD
Spread / Average Target
+239.51%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - CVRx, Inc.
  1. Stock Market
  2. Stocks
  3. CVRX Stock